12 /100
LOW RISK
Score updated May 29, 2026

EPRX — Eupraxia Pharmaceuticals Inc. Dilution Risk Tracker

Track EPRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track EPRX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
20
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for EPRX.
🔔 Track EPRX — Get forecast alerts →

💹 Market Data

Market Cap$482.11M
Shares Outstanding65.33M
Float50.32M
Cash$138.88M
Debt$2.01M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 2.0% shares (2025Q4 vs prior)
35 institutional holders · 13.88M shares
#1 Beutel, Goodman & Co Ltd. 3.71M shares
#2 Balyasny Asset Management L.P. 1.35M shares
#3 Vivo Capital, LLC 1.35M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.08M
Days to Cover17.8
% of Float6.1%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track EPRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking EPRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for EPRX
📊 EPRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 EPRX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.